After 62 years of regulating immunity, dexamethasone meets COVID-19
DW Cain, JA Cidlowski - Nature Reviews Immunology, 2020 - nature.com
DW Cain, JA Cidlowski
Nature Reviews Immunology, 2020•nature.comSix months into the COVID-19 pandemic, effective treatments have been frustratingly sparse.
The RECOVERY clinical trial, however, revealed that treatment with dexamethasone, a
classic synthetic glucocorticoid, enhanced survival of critically ill patients with COVID-19. In
this Comment, we discuss the immunological impacts of glucocorticoid therapy for COVID-
19.
The RECOVERY clinical trial, however, revealed that treatment with dexamethasone, a
classic synthetic glucocorticoid, enhanced survival of critically ill patients with COVID-19. In
this Comment, we discuss the immunological impacts of glucocorticoid therapy for COVID-
19.
Six months into the COVID-19 pandemic, effective treatments have been frustratingly sparse. The RECOVERY clinical trial, however, revealed that treatment with dexamethasone, a classic synthetic glucocorticoid, enhanced survival of critically ill patients with COVID-19. In this Comment, we discuss the immunological impacts of glucocorticoid therapy for COVID-19.
nature.com
